Moxifloxacin Ophthalmic
282 interactions 387 cited referencesMoxifloxacin ophthalmic solution is a fluoroquinolone antibiotic used to treat bacterial eye infections like pink eye. Read the full Moxifloxacin Ophthalmic drug information page →
Sources: FDA prescribing information (Structured Product Labeling), the published literature cited in each entry, DDInter 2.0 (a major open-access drug-interaction database), and legacy DrugBank interaction data distributed by the NIH's RxNav service (decommissioned in 2024) — analyzed and reviewed by our pharmacist team. How we build this library →
Major
Moxifloxacin Ophthalmic Mizolastine Increased risk of QT interval prolongation Details Moxifloxacin Ophthalmic Mobocertinib Exkivity An increased risk of QT interval prolongation Details Moxifloxacin Ophthalmic Nateglinide Starlix® Changes in blood glucose and increased risk of hypoglycemia or hyperglycemia Details Moxifloxacin Ophthalmic Nelfinavir Viracept Increased risk of QT interval prolongation Details Moxifloxacin Ophthalmic Nilotinib Increased risk of QT interval prolongation Details Moxifloxacin Ophthalmic Norfloxacin Increased risk of QT interval prolongation Details Moxifloxacin Ophthalmic Octreotide Bynfezia Increased risk of QT interval prolongation Details Moxifloxacin Ophthalmic Ofloxacin Floxin® Increased risk of QT interval prolongation Details Moxifloxacin Ophthalmic Olanzapine Increased risk of QT interval prolongation Details Moxifloxacin Ophthalmic Olodaterol Striverdi An increased risk of QT interval prolongation and an increased risk of ventricular arrhythmias Details Moxifloxacin Ophthalmic Ondansetron Increased risk of QT interval prolongation Details Moxifloxacin Ophthalmic Osilodrostat Isturisa Increased risk of QT interval prolongation Details Moxifloxacin Ophthalmic Osimertinib Tagrisso Increased risk of QT interval prolongation Details Moxifloxacin Ophthalmic Oxaliplatin Increased risk of QT-interval prolongation Details Moxifloxacin Ophthalmic Ozanimod Additive effects on heart rate Details Moxifloxacin Ophthalmic Pacritinib Vonjo® An increased risk of QT interval prolongation Details Moxifloxacin Ophthalmic Paliperidone Erzofri Increased risk of QT interval prolongation Details Moxifloxacin Ophthalmic Panobinostat Farydak Increased risk of QT interval prolongation Details Moxifloxacin Ophthalmic Paroxetine Paxil Increased risk of QT interval prolongation Details Moxifloxacin Ophthalmic Pasireotide Signifor Increased risk of QT prolongation Details Moxifloxacin Ophthalmic Pazopanib Votrient An increased risk of QT-interval prolongation Details Moxifloxacin Ophthalmic Pentamidine NebuPent Increased risk of QT interval prolongation Details Moxifloxacin Ophthalmic Perphenazine Increased risk of QT interval prolongation Details Moxifloxacin Ophthalmic Phenobarbital Fidoquel An increased risk of QT interval prolongation Details Moxifloxacin Ophthalmic Pimavanserin Nuplazid An increased risk of QT interval prolongation Details Moxifloxacin Ophthalmic Pioglitazone Actos Changes in blood glucose and increased risk of hypoglycemia or hyperglycemia Details Moxifloxacin Ophthalmic Pipamperone Increased risk of QT interval prolongation Details Moxifloxacin Ophthalmic Pitolisant Wakix Increased risk of QT interval prolongation Details Moxifloxacin Ophthalmic Ponesimod Ponvory An increased risk of QT interval prolongation Details Moxifloxacin Ophthalmic Porfimer Excessive intracellular damage in photosensitized tissues Details Moxifloxacin Ophthalmic Posaconazole Noxafil Increased risk of QT interval prolongation Details Moxifloxacin Ophthalmic Pramlintide Symlin Changes in blood glucose and increased risk of hypoglycemia or hyperglycemia Details Moxifloxacin Ophthalmic Prednisolone Flo-Pred® An increased risk of tendon rupture Details Moxifloxacin Ophthalmic Prednisone Deltasone An increased risk of tendon rupture Details Moxifloxacin Ophthalmic Primidone Mysoline An increased risk of QT interval prolongation Details Moxifloxacin Ophthalmic Probucol Increased risk of QT interval prolongation Details Moxifloxacin Ophthalmic Procainamide Procan® Increased risk of QT interval prolongation Details Moxifloxacin Ophthalmic Prochlorperazine Increased risk of QT interval prolongation Details Moxifloxacin Ophthalmic Promethazine Phenadoz Increased risk of QT interval prolongation Details Moxifloxacin Ophthalmic Propafenone Rythmol Increased risk of QT interval prolongation DetailsNo interactions on this page match that filter — try the next page or clear the filter.
Check another drug
Still have questions about this combination?
Every question gets a real answer from a licensed pharmacist — free, and usually within a day.
Ask the pharmacist